COMPASS Pathways (NASDAQ:CMPS – Get Free Report) is expected to be releasing its earnings data before the market opens on Thursday, February 27th. Analysts expect COMPASS Pathways to post earnings of ...

COMPASS Pathways (NASDAQ:CMPS – Free Report) had its price target reduced by HC Wainwright from $60.00 to $45.00 in a report ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, a ...

H.C. Wainwright lowered the firm’s price target on Compass Pathways (CMPS) to $45 from $60 and keeps a Buy rating on the shares. The firm says ...

India’s Digital Personal Data Protection Act, 2023 (“DPDPA”) marks a significant step in enhancing digital privacy by introducing Consent Managers, which will a ...

H.C. Wainwright analyst Patrick Trucchio revised the price target on Compass Pathways (NASDAQ:CMPS) stock, reducing it to $45 ...

For many patients, getting ready to have surgery means getting their blood drawn, their heart rhythm checked, or having other ...

DRDO has successfully tested drogue parachutes that will be very useful for astronauts during ISRO's Gaganyaan Mission. It ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...